Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG1852

DAAM1 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The DAAM1 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of human Raji B lymphocytes with targeted disruption of the DAAM1 gene. This model enables loss-of-function studies of the formin protein DAAM1, a key actin nucleator acting downstream of Wnt/PCP signaling and Dishevelled (DVL1/2/3). DAAM1 interacts with RhoA, Rac1, and profilin to regulate actin polymerization, filopodia formation, and cell migration. These knockout cells facilitate investigation of Wnt/PCP pathway dynamics, cytoskeletal remodeling, and lymphoma pathogenesis using assays such as immunofluorescence, migration assays, and RNA-seq.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    DAAM1

    Gene Identifier

    NCBI Gene ID 23002

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DAAM1 Knockout Raji Polyclonal Cells constitute a CRISPR/Cas9-mediated gene-disruption model in the human Raji B lymphocyte cell line. This polyclonal knockout cell population carries targeted disruption of the DAAM1 gene, providing a heterogeneous loss-of-function system to interrogate DAAM1-dependent actin dynamics and Wnt/PCP signaling. The use of polyclonal knockout cells eliminates clonal selection artifacts and enables robust analysis of DAAM1 biology across a pool of edited cells, suitable for functional assays that require population-level responses.

The Raji cell line is a well-established human EBV-positive Burkitt lymphoma model derived from B lymphocyte lineage. These suspension-adapted cells are widely employed in B-cell malignancy research, immunological signaling studies, and hematopoietic cancer drug screening. Their rapid proliferation, genetic stability, and well-characterized signal transduction networks make them an ideal host for CRISPR-based knockout studies, particularly for dissecting oncogenic pathways that intersect with cytoskeletal remodeling and cell polarity.

DAAM1 (Dishevelled-associated activator of morphogenesis 1) encodes a formin protein that functions as a critical actin nucleator downstream of the non-canonical Wnt/PCP pathway. Upon Wnt5a-Frizzled receptor activation, DAAM1 binds to Dishevelled (DVL1/2/3) and the Rho GTPases RhoA, Rac1, and Cdc42 to promote unbranched actin filament elongation and the formation of stress fibers and filopodia. DAAM1 also interacts with profilin to regulate actin monomer delivery and participates in feedback regulation of RhoA, linking cytoskeletal dynamics to transcriptional responses via ROCK, JNK, and c-Jun. Additionally, DAAM1 modulates ??-catenin signaling, bridging Wnt pathway branches.

In Raji B lymphocytes, DAAM1 contributes to cell migration, polarity, and proliferation??processes frequently dysregulated in lymphoma. Disruption of DAAM1 in this model is expected to impair Wnt/PCP-driven cytoskeletal rearrangements, leading to reduced filopodia formation, altered Rho GTPase activity, and diminished migratory capacity. This knockout system thus provides a relevant cellular context to study DAAM1??s role in B-cell malignancy progression, immune synapse formation, and potential contributions to neurodevelopmental disorder mechanisms through conserved actin regulatory functions.

The DAAM1 Knockout Raji Polyclonal Cells are well-suited for a range of research applications, including Wnt/PCP pathway dissection, actin cytoskeleton characterization, and lymphoma pathogenesis investigation. Users can assess DAAM1 protein levels and actin structures via Western blotting and immunofluorescence, probe protein?Cprotein interactions by co-immunoprecipitation, and evaluate migration and proliferation using standard assays. Transcriptomic and phenotypic profiling through RNA-seq and flow cytometry, along with Rho activity measurements, further enable comprehensive pathway analysis and drug target validation. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)